Compare Bintang Samudera Mandiri Lines Tbk (BSML) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bintang Samudera Mandiri Lines Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bintang Samudera Mandiri Lines Tbk trades at Rp525 (market cap 971.37B, 7.77M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Bintang Samudera Mandiri Lines Tbk is far larger — about 3.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Bintang Samudera Mandiri Lines Tbk is more actively traded (7.77M versus 41.7K). Which is the better fit depends on your goals.
| BSML | DGNS | |
|---|---|---|
Market Cap | 971.37B | 316.25B |
Volume | 7.77M | 41.7K |
Lot | 77.67K | 417 |
Turnover | 4.07B | 9.66M |
Average Price | 524.64 | 231.65 |
Value | 4.07B | 9.66M |
Indicative Equilibrium Price | 525 | 230 |
Indicative Equilibrium Volume | 41 | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bintang Samudera Mandiri Lines Tbk
PT Bintang Samudera Mandiri Lines Tbk (the Company) was established based on Notarial Deed No. 101 of Fransiskus Djoenardi, S.H., dated November 17, 2007. The Company has started its operations since 2017.
Read more on BSML →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
